Skip to main content
Clinical Trials/NCT05165030
NCT05165030
Completed
Not Applicable

Identification of Genetic Mutations Involved in Chiari Type I Malformations

Assistance Publique - Hôpitaux de Paris1 site in 1 country40 target enrollmentStarted: June 15, 2022Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Identification of the gene (s) whose mutations are responsible for the occurrence of a Chiari type I malformation, whether associated with syringomyelia or not.

Overview

Brief Summary

Although most cases of Chiari malformation type I (CM1) are sporadic, familial cases of CM1, with or without syringomyelia, suggest a genetic cause in the pathogenesis of these malformations.

The hypothesis is that there is one or more genes, in particular among those involved in the development of the axial skeleton and the cranium, which could lead to an abnormal morphology of the posterior fossa resulting in tonsillar herniation defining CM1.

The abnormal circulation of cerebrospinal fluid due to tonsillar herniation is believed to be responsible, in some patients whose predisposing factors remain to be determined, for the progressive onset of associated syringomyelia.

Since the determinants underlying the development of the posterior fossa of the skull are multigenic, the analysis of familial cases would make it possible to reduce genetic and phenotypic heterogeneity allowing to identify common pathogenic variants.

For this study the investigators will be taking a blood sample to perform whole exome sequencing, build a biological collection and record imaging and clinical data.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Having a social security
  • Participant or legal representative having given his consent
  • For patients: Diagnosis of a Chiari malformation type 1, defined morphologically as cerebellar tonsillar herniation beyond the foramen magnum greater than 5 mm, with or without associated syringomyelia, and which has at least one relating to the 1st or 2nd degree (parents, siblings; grandparents, uncles, aunts, cousins) carrying the malformation.
  • For relatives: at least two 1st degree relatives diagnosed with a Chiari type 1 malformation

Exclusion Criteria

  • Syndromic form of Chiari malformation
  • Patient with a legal protection measure
  • Pregnant or breastfeeding woman
  • Contraindication to MRI
  • For patients: diagnosis of Chiari malformation type 1 that could not be confirmed by MRI
  • For relatives: age under 18 years

Arms & Interventions

Blood Sample

Experimental

Blood Sample

Intervention: Blood Sample (Genetic)

Outcomes

Primary Outcomes

Identification of the gene (s) whose mutations are responsible for the occurrence of a Chiari type I malformation, whether associated with syringomyelia or not.

Time Frame: At inclusion (as soon as the patient agree)

Description of gene mutations in patients with Chiari type I malformation by whole exome sequencing

Secondary Outcomes

  • Identification of the gene (s) whose mutations are associated with the occurrence of syringomyelia in patients with Chiari type I malformation(At inclusion (as soon as the patient agree))
  • Establishment of a DNA bank for familial Chiari type I malformations(At inclusion (as soon as the patient agree))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials